School of Medicine


Showing 1,301-1,400 of 5,029 Results

  • Andrey Finegersh, MD, PhD

    Andrey Finegersh, MD, PhD

    Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)

    BioDr. Finegersh is a fellowship-trained head and neck surgical oncologist with board certification in otolaryngology and an Assistant Professor with the Stanford School of Medicine Department of Otolaryngology.

    He specializes in treatment of benign and malignant tumors of the head and neck and has received additional training in microvascular reconstruction and transoral robotic surgery. He takes tremendous pride in providing compassionate care for patients and managing challenging diagnoses.

    Dr. Finegersh completed his MD and PhD degrees at the University of Pittsburgh School of Medicine's combined Medical Scientist Training Program. He went on to complete residency in otolaryngology at the University of California San Diego (UCSD) and his fellowship at Stanford University, where he stayed on as faculty.

    He has extensive research experience in head and neck cancer epigenetics and completed post-doctoral research at the University of Pittsburgh and UCSD. He has received grants from the NIH and American Academy of Otolaryngology and has an active research lab studying molecular mechanisms of cancer. Dr. Finegersh has additional clinical interests in studying the role of minimally invasive surgery to improve outcomes for head and neck cancer patients.

  • Anna Finley Caulfield, MD

    Anna Finley Caulfield, MD

    Clinical Professor, Adult Neurology

    Current Research and Scholarly InterestsDr. Finley joined the Stanford Stroke Center in 2004 from Beth Israel Deaconess Medical Center in Boston. She cares for acute stroke patients and other neurologically critical ill patients in the intensive care unit. Currently, her research interests include hypothermia after cardiac arrest and comparing health care provider's predications of future neurological function in neurologically critical ill patients to their 6-month outcome.

  • David Fiorentino, MD, PhD

    David Fiorentino, MD, PhD

    Professor of Dermatology

    Current Research and Scholarly InterestsFrom a clinical standpoint, I am particularly focused in the care of patients with myositis or systemic sclerosis. We offer clinical trials, including novel, cutting-edge cellular-based (e.g. chimeric antigen receptor, or, CAR T) therapies for these diseases. We are particularly interested in understanding the role of auto antigens in providing windows into disease pathogenesis, as well as their potential direct role of autoantibodies in causing disease.

  • Andrew Fire

    Andrew Fire

    George D. Smith Professor of Molecular and Genetic Medicine and Professor of Pathology and of Genetics

    Current Research and Scholarly InterestsWhile chromosomal inheritance provides cells with one means for keeping and transmitting genetic information, numerous other mechanisms have (and remain to be) discovered. We study novel cellular mechanisms that enforce genetic constancy and permit genetic change. Underlying our studies are questions of the diversity of inheritance mechanisms, how cells distinguish such mechanisms as "wanted" versus "unwanted", and of the consequences and applications of such mechanisms in health and disease.

  • Michael Fischbach

    Michael Fischbach

    Liu (Liao) Family Professor

    Current Research and Scholarly InterestsThe microbiome carries out extraordinary feats of biology: it produces hundreds of molecules, many of which impact host physiology; modulates immune function potently and specifically; self-organizes biogeographically; and exhibits profound stability in the face of perturbations. Our lab studies the mechanisms of microbiome-host interactions. Our approach is based on two technologies we recently developed: a complex (119-member) defined gut community that serves as an analytically manageable but biologically relevant system for experimentation, and new genetic systems for common species from the microbiome. Using these systems, we investigate mechanisms at the community level and the strain level.

    1) Community-level mechanisms. A typical gut microbiome consists of 200-250 bacterial species that span >6 orders of magnitude in relative abundance. As a system, these bacteria carry out extraordinary feats of metabolite consumption and production, elicit a variety of specific immune cell populations, self-organize geographically and metabolically, and exhibit profound resilience against a wide range of perturbations. Yet remarkably little is known about how the community functions as a system. We are exploring this by asking two broad questions: How do groups of organisms work together to influence immune function? What are the mechanisms that govern metabolism and ecology at the 100+ strain scale? Our goal is to learn rules that will enable us to design communities that solve specific therapeutic problems.

    2) Strain-level mechanisms. Even though gut and skin colonists live in communities, individual strains can have an extraordinary impact on host biology. We focus on two broad (and partially overlapping) categories:

    Immune modulation: Can we redirect colonist-specific T cells against an antigen of interest by expressing it on the surface of a bacterium? How do skin colonists induce high levels of Staphylococcus-specific antibodies in mice and humans?

    Abundant microbiome-derived molecules: By constructing single-strain/single-gene knockouts in a complex defined community, we will ask: What are the effects of bacterially produced molecules on host metabolism and immunology? Can the molecular output of low-abundance organisms impact host physiology?

    3) Cell and gene therapy. We have begun two new efforts in mammalian cell and gene therapies. First, we are developing methods that enable cell-type specific delivery of genome editing payloads in vivo. We are especially interested in delivery vehicles that are customizable and easy to manufacture. Second, we have begun a comprehensive genome mining effort with an emphasis on understudied or entirely novel enzyme systems with utility in mammalian genome editing.

  • Michael Fischbein

    Michael Fischbein

    Thelma and Henry Doelger Professor of Cardiovascular Surgery

    Current Research and Scholarly InterestsMolecular and genetic mechanisms of aortic aneurysm/dissection development. Molecular mechanisms of aneurysm formation in Marfan Syndrome. Clinical research interests include thoracic aortic diseases (aneurysms, dissections).

  • Adina S. Fischer, MD, PhD

    Adina S. Fischer, MD, PhD

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioDr. Fischer’s research focuses on characterizing risk and resilience factors in depression. She has been awarded an NIH Career Development Award (K23) and Klingenstein Foundation Fellowship in Adolescent Depression to build her program of clinical and translational research at Stanford. Dr. Fischer's program of clinical care focused on the delivery and teaching of evidence-based clinical interventions that enhance resilience, with a focus on addressing the unique stressors encountered in academia and academic medicine that may contribute to risk and resilience in mood and anxiety disorders.

    Dr. Fischer’s translational program of research focuses on:
    (1) Improving our understanding of protective biomarkers of resilience to depression
    (2) Characterizing the effects of cannabis on neurobiological function and depressive symptoms
    (3) Developing neurobiologically-guided interventions for depressive disorders, particularly those that co-occur with cannabis and other substance use

    Dr. Fischer earned her BSc at the Massachusetts Institute of Technology in Brain and Cognitive Sciences, where she conducted research in the Early Childhood Cognition Laboratory. She then completed the MD/PhD Program at Dartmouth, where she obtained her PhD in in Neuroscience. Dr. Fischer’s doctoral research focused on characterizing the acute effects of cannabis in patients with schizophrenia and co-occurring cannabis use disorder. She then completed the Stanford Psychiatry Residency Training Program as a member of the Research Track, and an NIH funded T-32 postdoctoral research fellowship within the Department of Psychiatry and Behavioral Sciences.

  • Stephen Fischer

    Stephen Fischer

    Associate Professor of Anesthesia at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsPreoperative evaluation of the medically complex, patient; cost-effectiveness of preop diagnostic testing; patient, outcome studies in relation to preoperative preparation; computer, database of patient perioperative data; development of the, Anesthesia Preoperative Clinic as a model of quality, efficient, and, cost-effective care.

  • Kevin Fish

    Kevin Fish

    Professor of Anesthesia at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsNeurological dysfunction after cardiopulmonary bypass;, metabolism of inhalation anesthetics.

  • Ann Caroline Fisher, MD

    Ann Caroline Fisher, MD

    Clinical Professor, Ophthalmology

    BioCaroline Fisher, MD, is a Clinical Professor of Ophthalmology at Stanford University Hospital and Clinics. She specializes in cataract and glaucoma surgery, including minimally invasive glaucoma surgery.

    She completed her undergraduate education at Stanford University, obtaining both a Bachelor of Science degree in Biology and a Bachelor of Arts degree in Spanish, with Departmental Honors. She earned her medical degree from Stanford University School of Medicine and then went on to her internship at the University of Pennsylvania Presbyterian Hospital. She completed her ophthalmology residency at NYU/ Manhattan Eye, Ear, Throat Hospital. She then returned to Stanford for her Glaucoma Fellowship.

    Dr. Fisher is Director of the Stanford Belize Vision Clinic, dedicated to promoting eye health and care in Belize, and providing an international rotation for Stanford Ophthalmology Residents. She is also an Office of Faculty Development and Engagement Liaison and is currently one of the Stanford Network for Advancement and Promotion (SNAP) Cohort Leaders. Dr. Fisher is the Director of Development and Engagement for the Department of Ophthalmology.

  • George A. Fisher Jr.

    George A. Fisher Jr.

    Colleen Haas Chair in the School of Medicine, Emeritus

    Current Research and Scholarly InterestsClinical expertise in GI cancers with research which emphasizes Phase I and II clinical trials of novel therapies but also includes translational studies including biomarkers, molecular imaging, tumor immunology and development of immunotherapeutic trials.

  • Paul Graham Fisher, MD

    Paul Graham Fisher, MD

    Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health

    Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors and other cancers in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies.

  • Philip Andrew Fisher

    Philip Andrew Fisher

    Diana Chen Professor of Early Childhood Learning and Professor, by courtesy, of Pediatrics

    BioDr. Philip Fisher is the Diana Chen Professor of Early Childhood Learning in the Graduate School of Education and the Director of the Stanford Center on Early Childhood. His research, focuses on developing and evaluating scalable early childhood interventions in communities, and on translating scientific knowledge regarding healthy development under conditions of adversity for use in social policy and programs. He is particularly interested in the effects of early stressful experiences on children's development, and in prevention and treatment programs for improving children's functioning in areas such as relationships with caregivers and peers, social-emotional development, and academic achievement. He is currently the lead investigator in the ongoing RAPID-EC project, a national survey on the well-being of households with young children during the COVID-19 pandemic. Dr. Fisher is the developer of a number of widely implemented evidence-based interventions for supporting healthy child development in the context of social and economic adversity, including Treatment Foster Care Oregon for Preschoolers (TFCO-P) and Kids in Transition to School (KITS). Most recently, he developed the Filming Interactions to Nurture Development (FIND) video coaching program for supporting parenting in the home environment and early childhood care and education professionals in childcare and preschool contexts. He has published over 250 scientific papers in peer reviewed journals. He is the recipient of the 2012 Society for Prevention Research Translational Science Award, and a 2019 Fellow of the American Psychological Society.

  • Robert Fisher, MD, PhD

    Robert Fisher, MD, PhD

    The Maslah Saul, MD, Professor and Professor, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsDr. Fisher is interested in clincal, laboratory and translational aspects of epilepsy research. Prior work has included: electrical deep brain stimulation for epilepsy, studied in laboratory models and clinical trials; drug delivery to a seizure focus; mechanisms of absence epilepsy studied with in vitro slices of brain thalamus; hyperthermic seizures; diagnosis and treatment of non-epileptic seizures, the post-ictal state; driving and epilepsy; new antiepileptic drugs; surgery for epilepsy.

  • Daniel Owen Fishman

    Daniel Owen Fishman

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
    Clinical Assistant Professor (By courtesy), Medicine - Blood & Marrow Transplantation

    BioAfter graduating from Vanderbilt Medical School, Dr. Fishman completed the Psychiatry Residency Program at University of Pittsburgh Medical Center, where he served as Chief Resident and was lauded with the program’s sole Teaching Award. Thereafter, Dr. Fishman completed the Consultation-Liaison Psychiatry Fellowship also at the University of Pittsburgh Medical Center. During his training, he also served as Chief Fellow was elected into Alpha Omega Alpha, Honors Medical Society. In the subsequent years, Dr. Fishman practiced as a consultation and liaison psychiatrist, simultaneously serving both academic and community hospitals in the Greater Pittsburgh Area. In his outpatient clinic, he managed and treated patients with complex issues linking the domains of neurology and psychiatry, and specialized in nonepileptic episodes.

    Dr. Fishman joined the faculty of Stanford University School of Medicine in 2020 as a Clinical Assistant Professor of Psychiatry and Behavioral Sciences. Since his appointment, Dr. Fishman has led medical psychiatry services on the medical/surgical units, intensive care units and in the emergency department at Stanford Hospital to provide psychiatric care for patients with acute diagnoses and provide graduate medical education to psychiatry, internal medicine, palliative care, oncology, and neurology trainees. His work on developing a framework for evidence-based best practice guidelines was recognized with a 2020 DLIN/Fischer finalist award.

    Dr. Fishman is the appointed Chief of the Inpatient Proactive Psycho-Oncology Service, a service designed to proactively identify patients with psychopathology or who will require psychiatric intervention during their hospitalization. The service helps prevent development and escalation of psychopathology in the inpatient blood and marrow transplant and other cancer populations. His outpatient work is primarily as a psychiatric oncologist at the Stanford Cancer Center where he provides psychiatric consultation services and collaborates closely with his oncology colleagues to deliver comprehensive cancer care.

    His clinical and scholarly interests include the interface of medicine and psychiatry, psycho-oncology, catatonia, neuropsychiatry, collaborative care models, psychotherapy for the medically ill, interdisciplinary and graduate medical education.

  • Matthew Fitzgerald, PhD

    Matthew Fitzgerald, PhD

    Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS)

    Current Research and Scholarly InterestsMy research encompasses several translational projects. One focus is to modify the routine audiologic test battery such that it places equal weight on hearing acuity and hearing function. This work includes measures of speech in noise, or electrophysiologic responses such as the FFR. I also explore tools to better assess and maximize performance in users of hearing aids and cochlear implants. Finally, I am also investigating the benefits of telemedicine, and new treatments for tinnitus.

  • Peter Fitzgerald, MD, PhD

    Peter Fitzgerald, MD, PhD

    Professor (Research) of Medicine (Cardiovascular), Emeritus

    BioDr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University School of Medicine. He is an interventional cardiologist and holds a PhD in engineering. He is a professor in both the Department of Medicine and the Department of Engineering (by courtesy) at Stanford.

    Dr. Fitzgerald has led or participated in more than 175 clinical trials, has published more than 550 manuscripts and book chapters, and lectures worldwide. Over the past two decades, he has trained more than 150 postdoctoral researchers in engineering and medicine. Most recently, Dr. Fitzgerald completed two years of study toward a master’s degree focused on machine learning and agentic principles supporting AI.

    Dr. Fitzgerald has been a principal founder of 24 medical startups in the San Francisco Bay Area and has transitioned 17 of them to large medical device companies. He serves on several boards of directors and advises dozens of medical device startups, as well as multinational healthcare companies, on the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Dr. Fitzgerald was part of the founding team of LVP Capital, a venture firm focused on medical device and biotechnology startups in San Francisco. In 2010, he co-founded Triventures, an early-stage medical technology fund with offices in Palo Alto and Tel Aviv.

  • Caroline Fleck

    Caroline Fleck

    Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences

    BioDr. Caroline Fleck received her doctorate in Psychology & Neuroscience from Duke University, and went on to specialize in cognitive behavioral therapies including Exposure and Response Prevention, Dialectical Behavior Therapy, Parent Management Training, Gottman Method Couples Therapy, and Behavioral Activation. She is the founder and clinical director of Luma - a network of evidence-based clinicians in private practice. Dr. Fleck is also a trainer, educator, and public speaker on the topics of evidence-based approaches in psychology, mindfulness, and the use of technology in mental health care. Her lectures and courses at Stanford focus on training residents, post-docs, and faculty in Dialectical Behavior Therapy, and risk management.

    More information can be found on her website: https://www.drcarolinefleck.com/

  • Dominik Fleischmann

    Dominik Fleischmann

    Professor of Radiology (Cardiovascular Imaging)

    Current Research and Scholarly InterestsNon-invasive Cardiovascular Imaging
    Image Post-processing
    Contrast Medium Dynamics

  • Barry Fleisher

    Barry Fleisher

    Associate Professor of Pediatrics at the Lucile Salter Packard Children's Hospital, Emeritus

    Current Research and Scholarly InterestsNeonatology, neurobehavioral development, outcomes in premature infants.

  • Annesa Flentje

    Annesa Flentje

    Professor (Research) of Medicine (Stanford Prevention Research Center)

    BioAnnesa Flentje, PhD, is a Professor at Stanford University in the Stanford Prevention Research Center, Department of Medicine, School of Medicine. Dr. Flentje is a clinical psychologist who uses multiple methods to understand the impacts of stress and coping on human health and disease. Her research has investigated how stress directly impacts health outcomes and how these processes are mediated through both behaviors (e.g., substance use and coping) and molecular mechanisms (e.g., epigenetics and transcriptional regulation). Dr. Flentje has developed cognitive behavioral interventions to reduce stress, and identified these as a mechanism to alter immune pathways in gene expression. Dr. Flentje is currently leading a large comparative effectiveness study of two interventions for posttraumatic stress symptoms among LGBTQIA+ populations in California. Dr. Flentje has developed and led nationwide mentoring initiatives to support health research of understudied populations and translational research to improve health. Dr. Flentje is Co-Director of The PRIDE Study (pridestudy.org), a national longitudinal cohort study of LGBTQIA+ individuals within the United States that has enrolled over 30,000 participants and is approaching 10 years of data collection.

  • Pamela Flood

    Pamela Flood

    Adjunct Clinical Professor, Anesthesiology, Perioperative and Pain Medicine

    BioDr. Flood is a Professor at Stanford University who is fellowship trained in Pain Medicine and Obstetric Anesthesiology. She specializes in the treatment of chronic pelvic pain and multiple aspects of women's health including the prevention of chronic pain after childbirth. Research interests include the role of multimodal treatment in chronic pain conditions and prevention of persistent opioid use. Her research has spanned from detailed pharmacodynamic analysis, clinical trials to population health.

  • Lara Foland-Ross

    Lara Foland-Ross

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioI am an Academic Research Scientist in Neuroscience and Precision Mental Health in the Department of Psychiatry and Behavioral Sciences at Stanford University. I use a variety of imaging modalities to examine the neural and behavioral mechanisms of mood and cognition. The primary aim of my work is to understand how individual brain patterns can be leveraged in treatment planning for depression. My primary projects include the ACE-D study ("Accelerating Cognition-guided signatures to Enhance translation in Depression") in the Stanford Center for Precision Mental Health and Wellness. I deeply value the process of acting on curiosity, learning from challenges, and applying creative solutions to both highlight and address gaps in our understanding of depression and other mental health conditions.

  • Ann Folkins

    Ann Folkins

    Associate Professor of Pathology

    Current Research and Scholarly InterestsDr. Folkins' interest is in gynecologic and obstetric pathology, specifically in ovarian and endometrial malignancies and placental clinical-pathologic disorders.

  • Shawna Follis

    Shawna Follis

    Instructor, Epidemiology and Population Health
    Affiliate, Epidemiology and Population Health

    BioShawna Follis, PhD, MS, is an Instructor and K99 Fellow in Epidemiology, researching the risk factors of cardiometabolic diseases. She completed her postdoctoral training at Stanford, as a Propel Postdoctoral Scholar from 2021 to 2023 and a NIH T32 Postdoctoral Fellow from 2020 to 2021. She received her PhD in epidemiology at the University of Arizona and her master’s degree in anthropology from Purdue University.

  • Sai Folmsbee, MD, PhD

    Sai Folmsbee, MD, PhD

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsMy current research interest is the intersection of psychiatry and neuroimmunology. I am currently collaborating with Stanford Neuroimmunology in a retrospective analysis of patient data to determine the relationship between psychaitric medications and clinical outcomes in hospitalized patients with mutliple sclerosis, autoimmune encephalitis, and neuromyelitis optica.

  • Eric Foote

    Eric Foote

    Clinical Assistant Professor, Pediatrics - Neonatology

    BioEric Foote is a pediatric hospitalist with experience conducting clinical and public health research around the world. His research focuses on identifying and intervening on health disparities in low income countries and in low resource settings. Currently, he is developing and evaluating a community health worker-led household phototherapy intervention to extend access to neonatal jaundice care for newborns in rural Bangladesh. He is also working to improve SARS-CoV-2 testing and genomic surveillance across California and worldwide.

  • James Ford

    James Ford

    Professor of Medicine (Oncology) and of Genetics and, by courtesy, of Pediatrics

    Current Research and Scholarly InterestsMammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNA damage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer.

  • Judith Ford

    Judith Ford

    Professor (Research) of Psychiatry and Behavioral Sciences, Emeritus

    Current Research and Scholarly InterestsWe are using functional brain imaging methods (electrophysiology and magnetic resonance imaging) to study symptoms of schizophrenia such as auditory hallucinations, self-monitoring failures, emotional blunting, and cognitive deficits.

  • Polly Fordyce

    Polly Fordyce

    Associate Professor of Bioengineering and of Genetics

    Current Research and Scholarly InterestsThe Fordyce Lab is focused on developing new instrumentation and assays for making quantitative, systems-scale biophysical measurements of molecular interactions. Current research in the lab is focused on three main platforms: (1) arrays of valved reaction chambers for high-throughput protein expression and characterization, (2) spectrally encoded beads for multiplexed bioassays, and (3) sortable droplets and microwells for single-cell assays.

  • Joseph (Joe) D Forrester MD MSc FACS

    Joseph (Joe) D Forrester MD MSc FACS

    Associate Professor of Surgery (General Surgery)

    Current Research and Scholarly InterestsI am broadly interested in research exploring the care of the injured patient both in high- and low-resource settings. I have specific on-going projects assessing surgical site infection surveillance in low-resource settings, and surgical management of acute and chronic non-union rib fractures.

  • Stephen P. Fortmann, MD

    Stephen P. Fortmann, MD

    C.F. Rehnborg Professor in Disease Prevention, Emeritus

    Current Research and Scholarly InterestsDr. Fortmann's interests include population-level (community) prevention of cardiovascular disease, the epidemiology and prevention of chronic diseases, and the effects of the built environment on health. He has conducted research projects addressing tobacco use cessation, tobacco control policy, the role of retail marketing on youth tobacco use, nutrition education, blood pressure control, and lipid disorders.

  • Deshka Foster, MD, PhD

    Deshka Foster, MD, PhD

    Assistant Professor of Surgery (General Surgery)

    Current Research and Scholarly InterestsCancer associated fibroblasts in hepatopancreatobiliary (HPB) malignancies, tumor microenvironment, abdominal adhesion biology and fibrosis

  • Steven Foung

    Steven Foung

    Professor of Pathology

    Current Research and Scholarly InterestsOur research focus is define correlates of protection against hepatitis C virus and other viral pathogens. Detailed characterization of broadly neutralizing human or nonhuman primate monoclonal antibodies against these agents will create high-resolution, functional maps of linear and nonlinear epitopes comprising the major binding sites of both isolate-specific and broadly neutralizing antibodies for rational vaccine design.

  • Virginia Fowkes

    Virginia Fowkes

    Senior Lecturer in Medicine (Family and Community Medicine)
    Casual Employee, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsEvaluation of academic-community programs for health professionals in medically underserved areas
    Training of health professionals for medically underserved areas/populations
    Program development in medical education (Family Medicine and (AHECs)
    National and state policy workforce development

  • Michael B. Fowler, MBBS, FRCP

    Michael B. Fowler, MBBS, FRCP

    Professor of Medicine (Cardiovascular), Emeritus

    Current Research and Scholarly InterestsAdrenergic nervous system; beta-adrenergic function in, heart failure; drugs in heart failure.

  • Andrea Fox

    Andrea Fox

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioAndrea is a certified Physician Assistant who joined Stanford Health Care in 2019 to develop a comprehensive Fracture Liaison Service and bone health clinic championed by Dr. Michael Gardner, Trauma Orthopaedist. Andrea earned a Masters degree in Medical Science, Physician Assistant Studies and a Masters in Health Administration, both from the University of Missouri. She holds a current certification with the International Society of Clinical Densitometry and has completed her certificate trained as a fracture liaison clinician through the National Osteoporosis Foundation. She has a keen interest in educating primary care providers and the general public on the importance of early monitoring, risk factors and treatment for bone loss and the prevention and healing of fractures.

  • Paige Fox, MD, PhD, FACS

    Paige Fox, MD, PhD, FACS

    Associate Professor of Surgery (Plastic and Reconstructive Surgery)

    BioDr. Paige Fox is Board Certified Plastic Surgeon who specializes in hand surgery, reconstructive microsurgery including facial reanimation, as well as peripheral nerve and brachial plexus surgery. She is an Associate Professor in the Division of Plastic and Reconstructive surgery in the Department of Surgery. She works with adult and pediatric patients. Her lab focuses on wound healing and nerve compression. She has clinical research interested in optimizing care of upper extremity and nerve disorders both in the US and internationally. Dr. Fox has a passion for sustainability and health care's effect on the environment. She is involved in efforts to green the OR and the clinics at Stanford.

  • Katie Fracalanza, PhD

    Katie Fracalanza, PhD

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsDr. Fracalanza is interested in factors underlying the development and maintenance of mood and anxiety disorders. She has conducted research on cognitive factors thought to maintain anxiety, such as intolerance of uncertainty and perfectionism. She is interested in the patient perspective, and conducting research from a qualitative lens to better understand this.

  • Benjamin Lewis Franc

    Benjamin Lewis Franc

    Clinical Professor, Radiology - Rad/Nuclear Medicine

    BioDr. Franc is a Clinical Professor of Radiology - Nuclear Medicine and Molecular Imaging. He completed his B.S and M.S. in Chemical Engineering at Stanford University, Stanford, CA. He completed his medical school training at University of Southern California, Keck School of Medicine. While conducting his residency at Stanford University, in the Division of Nuclear Medicine and Molecular Imaging, he was also the chief resident. Dr. Franc’s research interests include all aspects of PET-CT as he has nearly 20 years of experience in clinical Nuclear Medicine with particular expertise in PET-CT.

    Dr. Franc predominantly publishes and lectures on applications and innovations of PET-CT. He has proficiency in all aspects of PET radiopharmaceutical development, spanning the design of molecules, synthesis of radioligands, and use in animal and human imaging. He also has expertise in quantitative image analysis, development of novel post-processing image reconstruction methods, and the application of artificial intelligence in human diagnostics. Dr. Franc has implemented new radiopharmaceuticals in pre-clinical and clinical research PET imaging as well as for clinical PET with applications in cancer, infectious disease (HIV), and autoimmune disease (RA). He has applied advanced computational techniques, including deep learning, to extract predictive data for prognosis of various cancers and neurodegenerative diseases from molecular imaging modalities.

    Since joining the faculty at Stanford in 2018, Dr. Franc has received several awards including the Radiological Society of North America 2019 Margulis Award for Excellence in Research; RSNA 2019 Trainee Research; and Most read article in Radiology 2019. He has accepted the position of Director, Residency Program, Nuclear Medicine and Molecular Imaging as well as the Director, Radiology Value-Based Care Initiative. Dr. Franc has presented more than 40 abstracts at national and international meetings and published more than 90 papers in peer-reviewed publications, as well as 9 book chapters.

  • Uta Francke

    Uta Francke

    Professor of Genetics and of Pediatrics, Emerita

    Current Research and Scholarly InterestsFunctional consequences and pathogenetic mechanisms of mutations and microdeletions in human neurogenetic syndromes and mouse models. Integration of genomic information into medical care.

  • Curtis Frank

    Curtis Frank

    W. M. Keck, Sr. Professor in Engineering, Emeritus

    BioThe properties of ultrathin polymer films are often different from their bulk counterparts. We use spin casting, Langmuir-Blodgett deposition, and surface grafting to fabricate ultrathin films in the range of 100 to 1000 Angstroms thick. Macromolecular amphiphiles are examined at the air-water interface by surface pressure, Brewster angle microscopy, and interfacial shear measurements and on solid substrates by atomic force microscopy, FTIR, and ellipsometry. A vapor-deposition-polymerization process has been developed for covalent grafting of poly(amino acids) from solid substrates. FTIR measurements permit study of secondary structures (right and left-handed alpha helices, parallel and anti-parallel beta sheets) as a function of temperature and environment.

    A broadly interdisciplinary collaboration has been established with the Department of Ophthalmology in the Stanford School of Medicine. We have designed and synthesized a fully interpenetrating network of two different hydrogel materials that have properties consistent with application as a substitute for the human cornea: high water swellability up to 85%,tensile strength comparable to the cornea, high glucose permeability comparable to the cornea, and sufficient tear strength to permit suturing. We have developed a technique for surface modification with adhesion peptides that allows binding of collagen and subsequent growth of epithelial cells. Broad questions on the relationships among molecular structure, processing protocol, and biomedical device application are being pursued.

  • Matthew Frank

    Matthew Frank

    Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

    BioDr. Matthew Frank, MD, PhD, is an Assistant Professor of Medicine in the Division of Blood and Marrow Transplantation and Cellular Therapy at Stanford University. Dr. Frank predominantly cares for patients with high-risk lymphoma and other blood cancers. He is a lead investigator of clinical trials evaluating the safety and effectiveness of cancer treatments called chimeric antigen receptor (CAR ) T therapy for patients with lymphomas and leukemias. Dr. Frank’s research focuses on developing methods to identify patients who are at high risk for relapse or developing side-effects after receiving CAR T therapy and to understand why these relapses and side-effects occur.

  • Michael Frank

    Michael Frank

    Benjamin Scott Crocker Professor of Human Biology and Professor, by courtesy, of Linguistics

    Current Research and Scholarly InterestsHow do we learn to communicate using language? I study children's language learning and how it interacts with their developing understanding of the social world. I use behavioral experiments, computational tools, and novel measurement methods like large-scale web-based studies, eye-tracking, and head-mounted cameras.

  • Lorry Frankel

    Lorry Frankel

    Professor of Pediatrics (Critical Care) at the Lucile Salter Packard Children's Hospital at Stanford, Emeritus

    Current Research and Scholarly Interests1) Collaborative efforts with Dale Umetsu and Dave Lewis in evaluating alveolar macrophage response to antigen. We try to examine cytokine activation and inhibition. I perform bronchoalveolar lavage in these patients in order to obtain alveolar macrophages which we culture, stimulate and study.
    2) Evaluate outcomes for patients admitted to the Pediatric Intensive Care Unit from the EMS services for trauma and other life-threatening events.

  • Jennifer Frankovich

    Jennifer Frankovich

    Clinical Professor, Pediatrics - Rheumatology

    Current Research and Scholarly InterestsMy primary interest and role at Stanford is to evaluate and treat children with both systemic and organ specific autoimmune disease. In October of 2012, we started a multidisciplinary clinic dedicated to treating patients with PANS (Pediatric Acute-onset Neuropsychiatric Syndromes). I am currently the clinical and research director for the PANS program.

  • Hunter Fraser

    Hunter Fraser

    Professor of Biology

    Current Research and Scholarly InterestsWe study the evolution of complex traits by developing new experimental and computational methods.

    Our work brings together quantitative genetics, genomics, epigenetics, and evolutionary biology to achieve a deeper understanding of how genetic variation shapes the phenotypic diversity of life. Our main focus is on the evolution of gene expression, which is the primary fuel for natural selection. Our long-term goal is to be able to introduce complex traits into new species via genome editing.

  • Susan M. Frayne, MD, MPH

    Susan M. Frayne, MD, MPH

    Professor of Medicine (General Medical Discipline)

    Current Research and Scholarly InterestsPrimary care for mentally ill patients, particularly post-traumatic stress disorder in women seconday to sexual trauma.

  • William James Frederick

    William James Frederick

    Clinical Associate Professor, Medicine

    BioDr. William James Frederick III is the Medical Director of Case Management, Utilization Management, and the Physician Advisor Medical Director at Stanford Health Care. Prior to moving to Stanford in August 2023, Dr. Frederick was a Physician Advisor and Clinical Associate Professor of Medicine at UC San Diego Health. As an expert in Healthcare Quality Care Management, he has started internal physician advisor programs, redesigned utilization management workflow, led quality improvement initiatives around readmissions and length of stay, developed a General Inpatient Hospice program, partnered with a critical illness recovery hospital to improve quality and patient care, revamped and expanded health system charity policies, and implemented multidisciplinary team rounding. As a medical educator, Dr. Frederick served as the Course Director for 4th year medical students during inpatient medicine rotations across four hospitals. As an Internal Medicine Core Faculty Member, he instituted a weekly resident quality improvement and patient safety conference. He provided ongoing education to faculty, staff, and trainees on topics of inpatient clinical care, ethical use of hospice, critical illness recovery hospitals, patient flow, and quality management. His desire to give back to the community led him to service as faculty chair of the UC San Diego Faculty and Staff giving council.

    Dr. Frederick is board certified in both Internal Medicine and Health Care Quality Management with a sub-certification as a Physician Advisor. He completed his residency at Santa Clara Valley Medical Center and earned both an MD and PhD in Electrical and Computer Engineering from UC Davis. He holds a BS in Bioengineering from UC San Diego. He began his career by serving in the United States Marine Corps as infantryman from 1989-1993.

  • Michael Fredericson, MD

    Michael Fredericson, MD

    Professor of Orthopaedic Surgery and, by courtesy, of Medicine (Stanford Prevention Research Center)

    Current Research and Scholarly InterestsMy research focuses on the etiology, prevention, and treatment of overuse sports injuries in athletes and lifestyle medicine practices for improved health and longevity.

  • Michael T. Freehill, MD, FAOA

    Michael T. Freehill, MD, FAOA

    Associate Professor of Orthopaedic Surgery

    BioDr. Freehill is a board-certified, double fellowship-trained specialist in orthopaedic surgery with a sub-specialty certification in sports medicine and serves as Chief of Shoulder & Elbow Surgery. His concentration is in shoulder and sports elbow. Dr. Freehill serves as Head Team physician for the Athletics Major League Baseball organization. He is also a team physician for Stanford University athletics and Head Team physician for the Stanford University baseball.

    Dr. Freehill’s practice focuses on all shoulder conditions including rotator cuff tears, instability, arthritis, arthropathy, complex shoulder pathology, and sports related shoulder injury. In addition, he is also passionate about sports-related elbow injuries, with an emphasis on thrower’s elbow.

    Professional and amateur athletes, as well as non-athletes, come to Dr. Freehill for expert care. His sports medicine training and specialization in shoulder replacement procedures enable him to treat patients across the lifespan. Depending on factors including the patient’s condition and occupation, he may recommend treatment ranging from non-operative solutions (such as physical therapy), to cutting-edge biologics procedures, to complex surgery.

    Previously, he was a team physician for the Detroit Tigers and the Winston-Salem Dash (affiliated with the Chicago White Sox); he assisted with the Baltimore Orioles while in residency. He has also served as Director of Sports Medicine for Wake Forest University Athletics.

    As executive director of the Stanford Baseball Science CORE, Dr. Freehill draws on his previous experience as a professional baseball player to help athletes of all skill levels and push baseball science forward. He conducts cutting edge research on the biomechanics of overhead throwers and has studied pitch counts in adolescent players funded by Major League Baseball and is currently studying post-ulnar collateral ligament surgery in professional baseball hitters funded by the American Orthopaedic Society for Sports Medicine. (AOSSM). He is a member of the MLB Team Physicians Association and its Research Committee. Additionally, he was the pioneering mind behind the Pitching Lab at Wake Forest.

    Dr. Freehill has pioneered the use of some of the latest techniques and technology for leading-edge shoulder care. Among the advanced technologies he utilizes is a virtual reality (VR) planning software system that enables him to perform a simulated shoulder arthroplasty procedure prior to entering the operating room with a patient. He is also a member of the robotics team which will revolutionize the manner in which shoulder replacement is performed.

    Dr. Freehill has over 100 peer-reviewed articles and his work has been featured in the American Journal of Sports Medicine, Orthopedic Journal of Sports Medicine, Journal of Shoulder and Elbow Surgery, Arthroscopy, and elsewhere. He has written numerous book chapters and made over 400 presentations at regional, national, and international conferences. Dr. Freehill’s honors include the Orthopaedic Residency Research Award in residency at Johns Hopkins University. He is also a Neer Award winner, denoting the highest research award selected annually by the American Shoulder and Elbow Society and was awarded a research grant from the National Institutes of Health to investigate stromal vascular fractionated mesenchymal cells and their potential for healing rotator cuff tendon tears.

    Currently, the Associate Editor for Shoulder & Elbow for the American Journal of Sports Medicine, he is also a committee member for the American Shoulder and Elbow Surgeons Society, American Orthopaedic Society for Sports Medicine, International Congress of Arthroscopy and Sports Traumatology, Arthroscopy Association of North America, and American Academy of Orthopaedic Surgeons, American Orthopaedic Association and has been elected into the Herodicus Society.

  • Shai Friedland

    Shai Friedland

    Professor of Medicine (Gastroenterology and Hepatology)

    Current Research and Scholarly Interests1. Gastrointestinal Endoscopy- Techniques and Outcomes
    2. Noninvasive colorectal cancer screening
    3. Medical device development in gastroenterology

  • Lisa Aviva Friedman

    Lisa Aviva Friedman

    Clinical Instructor, Pathology

    BioLisa Friedman completed hematopathology and renal pathology fellowships at Stanford University following residency training at the University of Virginia. She is board certified in hematopathology, anatomic pathology, and clinical pathology. She has an interest in patient care, medical education, and interdisciplinary collaboration.

  • Jason Alan Fries

    Jason Alan Fries

    Assistant Professor of Biomedical Data Science and of Medicine (BMIR)

    BioJason Fries' research focuses on training and evaluating foundation models for healthcare, positioned at the intersection of computer science, medical informatics, and hospital systems. His work explores the use of electronic health record (EHR) data to contextualize human health, leveraging longitudinal patient information to inform model development and evaluation. His research has been published in venues such as NeurIPS, ICLR, AAAI, Nature Communications, Nature Medicine and npj Digital Medicine.

  • Richard Frock

    Richard Frock

    Assistant Professor of Radiation Oncology (Radiation and Cancer Biology)

    Current Research and Scholarly InterestsWe are a functional genomics laboratory interested in elucidating mechanisms of DNA repair pathway choice and genome instability. We use genome-wide repair fate maps of targeted DNA double strand breaks (DSBs) to develop pathway-specific models and combinatorial therapies. Our expertise overlaps many different fields including: genome editing, ionizing radiation, cancer therapeutics, V(D)J and IgH class switch recombination, repair during transcription and replication, and meiosis.

  • Victor Froelicher, MD

    Victor Froelicher, MD

    Professor of Medicine (Cardiovascular) at the Veterans Affairs Palo Alto Health Care System, Emeritus

    Current Research and Scholarly InterestsScreening of athletes for sudden cardiac death, Computerized ECG and clinical data management; exercise Physiology including expired gas analysis; the effect of chronic and acute exercise on the heart; digital recording of biological signals; diagnostic use of exercise testing; development of Expert Medical System software and educational tools.

  • Judith Frydman

    Judith Frydman

    Donald Kennedy Chair in the School of Humanities and Sciences and Professor of Genetics

    Current Research and Scholarly InterestsThe long term goal of our research is to understand how proteins fold in living cells. My lab uses a multidisciplinary approach to address fundamental questions about molecular chaperones, protein folding and degradation. In addition to basic mechanistic principles, we aim to define how impairment of cellular folding and quality control are linked to disease, including cancer and neurodegenerative diseases and examine whether reengineering chaperone networks can provide therapeutic strategies.

  • Adam Frymoyer

    Adam Frymoyer

    Clinical Professor, Pediatrics - Neonatology

    Current Research and Scholarly InterestsMy research interests focus on understanding the clinical pharmacokinetics (PK) and pharmacodynamics (PD) of medicines used in complex pediatric populations. This includes identifying sources of variation in drug response through the application of population PK-PD modeling and simulation approaches. The goal is to ultimately apply this quantitative understanding to guide therapeutic decision-making in infants and children.

  • Janene Fuerch

    Janene Fuerch

    Clinical Associate Professor, Pediatrics - Neonatology

    BioJanene H. Fuerch, MD is a Clinical Associate Professor of Neonatology at Stanford University Medical Center, as well as an innovator, educator, researcher and physician entrepreneur. She has an undergraduate degree in Neuroscience from Brown University and a medical degree from the Jacobs School of Medicine at SUNY Buffalo. At Stanford University she completed a pediatrics residency, neonatal-perinatal medicine fellowship and the Byers Center for Biodesign Innovation Fellowship.

    She is also Assistant Director of the Biodesign Innovation Fellowship Program at Stanford University, and Co-Director of Impact1 where she mentors and advises new entrepreneurs through all aspects of medical device development, from identifying clinical needs to commercialization. Her specific areas of investigational interest include the development and commercialization process of neonatal, pediatric and maternal health medical devices as well as the utilization of a simulated environment to develop and test medical devices. She is a national leader in neonatal resuscitation, ECMO, device development and has been an AHRQ and FDA funded investigator. But her work extends outside of the academic realm to industry having co-founded EMME (acquired by Simple Health 2022) an award-winning reproductive health company, medical director for Novonate (acquired by Laborie 2023) a neonatal umbilical catheter securement company and notable consultant for Vitara (EXTEND - artificial environment to decrease complications of prematurity), and Avanos™. Janene is passionate about improving the health of children and newborns through medical device innovation and research.

  • Eri Fukaya

    Eri Fukaya

    Clinical Professor, Surgery - Vascular Surgery
    Clinical Professor, Medicine - Primary Care and Population Health

    BioDr. Fukaya practices Vascular Medicine at the Stanford Vascular Clinics and Advanced Wound Care Center. She received her medical education in Tokyo and completed her medical training both in the US and Japan. She joined Stanford in 2015.

    Vascular Medicine covers a wide range of vascular disorders including chronic venous insufficiency, varicose veins, deep vein thrombosis, post thrombotic syndrome, peripheral artery disease, carotid artery disease, cardiovascular risk evaluation, fibromuscular dysplasia, rare vascular disease, lymphedema, arterial/venous/diabetic ulcers, and wound care.

    Dr. Fukaya has a special interest in venous disease and started the Stanford Vascular and Vein Clinic in 2016.

    Board Certified in Vascular Medicine
    Board Certified in Internal Medicine
    Board Certified in Internal Medicine (Japan)
    Board Certified in Plastic and Reconstructive Surgery (Japan)

  • Gerald Fuller

    Gerald Fuller

    Fletcher Jones Professor in the School of Engineering

    BioThe processing of complex liquids (polymers, suspensions, emulsions, biological fluids) alters their microstructure through orientation and deformation of their constitutive elements. In the case of polymeric liquids, it is of interest to obtain in situ measurements of segmental orientation and optical methods have proven to be an excellent means of acquiring this information. Research in our laboratory has resulted in a number of techniques in optical rheometry such as high-speed polarimetry (birefringence and dichroism) and various microscopy methods (fluorescence, phase contrast, and atomic force microscopy).

    The microstructure of polymeric and other complex materials also cause them to have interesting physical properties and respond to different flow conditions in unusual manners. In our laboratory, we are equipped with instruments that are able to characterize these materials such as shear rheometer, capillary break up extensional rheometer, and 2D extensional rheometer. Then, the response of these materials to different flow conditions can be visualized and analyzed in detail using high speed imaging devices at up to 2,000 frames per second.

    There are numerous processes encountered in nature and industry where the deformation of fluid-fluid interfaces is of central importance. Examples from nature include deformation of the red blood cell in small capillaries, cell division and structure and composition of the tear film. Industrial applications include the processing of emulsions and foams, and the atomization of droplets in ink-jet printing. In our laboratory, fundamental research is in progress to understand the orientation and deformation of monolayers at the molecular level. These experiments employ state of the art optical methods such as polarization modulated dichroism, fluorescence microscopy, and Brewster angle microscopy to obtain in situ measurements of polymer films and small molecule amphiphile monolayers subject to flow. Langmuir troughs are used as the experimental platform so that the thermodynamic state of the monolayers can be systematically controlled. For the first time, well characterized, homogeneous surface flows have been developed, and real time measurements of molecular and microdomain orientation have been obtained. These microstructural experiments are complemented by measurements of the macroscopic, mechanical properties of the films.

  • Margaret T. Fuller

    Margaret T. Fuller

    Reed-Hodgson Professor of Human Biology, Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor of Genetics and of Obstetrics/Gynecology (Reproductive and Stem Cell Biology)

    Current Research and Scholarly InterestsRegulation of self-renewal, proliferation and differentiation in adult stem cell lineages. Developmental tumor suppressor mechanisms and regulation of the switch from proliferation to differentiation. Cell type specific transcription machinery and regulation of cell differentiation. Developmental regulation of cell cycle progression during male meiosis.